{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:20:55Z","timestamp":1793647255945,"version":"4.5.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bmc.2022.117111","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T13:25:02Z","timestamp":1669728302000},"page":"117111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase"],"prefix":"10.1016","volume":"77","author":[{"given":"Chnar","family":"Kakakhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00fcneyt","family":"T\u00fcrke\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zcan","family":"G\u00fcle\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"\u00d6zkemahl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckr\u00fc","family":"Beydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.117111_b0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/cr5004216","article-title":"Chemistry of \u03b1-Oxoesters: A Powerful Tool for the Synthesis of Heterocycles","volume":"115","author":"Eftekhari-Sis","year":"2015","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2022.117111_b0010","doi-asserted-by":"crossref","unstructured":"I.A. Carbajal-Valenzuela, N.M. Apolonio\u2013Hernandez, D.V. Gutierrez-Chavez, B. Gonz\u00e1lez-Arias, A. Jimenez-Hernandez, I. torres-Pacheco, E. Rico-Garc\u00eda, A.A. Feregrino-P\u00e9rez, R.G. Guevara-Gonz\u00e1lez, Chapter 5 - Biological macromolecules as nutraceuticals, in: A.K. Nayak, A.K. Dhara, D. Pal (Eds.) Biological Macromolecules, Academic Press2022, pp. 97-138.","DOI":"10.1016\/B978-0-323-85759-8.00001-4"},{"key":"10.1016\/j.bmc.2022.117111_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114576","article-title":"Seeking heterocyclic scaffolds as antivirals against dengue virus","volume":"240","author":"De","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4236\/ijoc.2020.102003","article-title":"Design, Synthesis, Chemistry and Biological Evaluation of Some Polyfunctional Heterocyclic Nitrogen Systems\u2014Overview","volume":"10","author":"Alanzy","year":"2020","journal-title":"Int J Org Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0025","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1021\/acs.jmedchem.1c01859","article-title":"Incorporating Selenium into Heterocycles and Natural Products\u2500From Chemical Properties to Pharmacological Activities","volume":"65","author":"Hou","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0030","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.procbio.2022.06.009","article-title":"Pharmacological significance of nitrogen-containing five and six-membered heterocyclic scaffolds as potent cholinesterase inhibitors for drug discovery","volume":"120","author":"Obaid","year":"2022","journal-title":"Process Biochem"},{"key":"10.1016\/j.bmc.2022.117111_b0035","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1021\/jm050408c","article-title":"4-Aryl-1,2,3-triazole: A Novel Template for a Reversible Methionine Aminopeptidase 2 Inhibitor, Optimized To Inhibit Angiogenesis in Vivo","volume":"48","author":"Kallander","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2010.10.038","article-title":"Triazoles and tetrazoles: Prime ligands to generate remarkable coordination materials","volume":"255","author":"Arom\u00ed","year":"2011","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.bmc.2022.117111_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128004","article-title":"Design and synthesis, biological evaluation of bis-(1,2,3- and 1,2,4)-triazole derivatives as potential antimicrobial and antifungal agents","volume":"41","author":"Bitla","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2022.117111_b0050","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","article-title":"The 1,2,3-triazole ring as a bioisostere in medicinal chemistry","volume":"22","author":"Bonandi","year":"2017","journal-title":"Drug Disc. T."},{"key":"10.1016\/j.bmc.2022.117111_b0055","doi-asserted-by":"crossref","first-page":"2000223","DOI":"10.1002\/ardp.202000223","article-title":"1,2,4-Triazole hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus","volume":"354","author":"Ge","year":"2021","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2022.117111_b0060","doi-asserted-by":"crossref","first-page":"12397","DOI":"10.1021\/acs.jmedchem.1c01075","article-title":"Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies","volume":"64","author":"Rahman","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0065","doi-asserted-by":"crossref","first-page":"14502","DOI":"10.1021\/jacs.1c08704","article-title":"(Hetero)arylazo-1,2,3-triazoles: \u201cClicked\u201d Photoswitches for Versatile Functionalization and Electronic Decoupling","volume":"143","author":"Fang","year":"2021","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2022.117111_b0070","doi-asserted-by":"crossref","first-page":"10902","DOI":"10.1021\/acs.joc.2c01186","article-title":"Re-Evaluation of Product Outcomes in the Rh-Catalyzed Ring Expansion of Aziridines with N-Sulfonyl-1,2,3-Triazoles","volume":"87","author":"Dequina","year":"2022","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0075","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1039\/D1NR08338D","article-title":"Multivalent non-covalent interactions lead to strongest polymer adhesion","volume":"14","author":"Lallemang","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.bmc.2022.117111_b0080","unstructured":"L. Cicco, F.M. Perna, A. Falcicchio, A. Altomare, F. Messa, A. Salomone, V. Capriati, P. Vitale, 1,3-Dipolar Cycloaddition of Alkanone Enolates with Azides in Deep Eutectic Solvents for the Metal-free Regioselective Synthesis of Densely Functionalized 1,2,3-Triazoles, Eur. J. Org. Chem., n\/a. 10.1002\/ejoc.202200843."},{"key":"10.1016\/j.bmc.2022.117111_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelechem.2022.116056","article-title":"Electrochemical oxidation assisted with the 1,3-dipolar cycloaddition for the synthesis of the new substituted triazole","volume":"907","author":"Mehrdadian","year":"2022","journal-title":"J Electroanal Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0090","doi-asserted-by":"crossref","unstructured":"A. Oubella, A. Bimoussa, S. Byadi, M. Fawzi, Y. Laamari, A. Auhmani, H. Morjani, A. Robert, A. Riahi, M.Y. Ait Itto, Design, synthesis, in vitro anticancer activity, and molecular docking studies of new (R)-carvone-pyrazole-1,2,3-triazoles, J. Mol. Struct., 1265 (2022) 133383. 10.1016\/j.molstruc.2022.133383.","DOI":"10.1016\/j.molstruc.2022.133383"},{"key":"10.1016\/j.bmc.2022.117111_b0095","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1002\/ejoc.201301695","article-title":"1,2,3-Triazole in Heterocyclic Compounds, Endowed with Biological Activity, through 1,3-Dipolar Cycloadditions","volume":"2014","author":"Lauria","year":"2014","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: Current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejmech.2017.05.057","article-title":"Azide-alkyne cycloaddition towards 1H\u20131,2,3-triazole-tethered gatifloxacin and isatin conjugates: Design, synthesis and in vitro anti-mycobacterial evaluation","volume":"138","author":"Xu","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0110","doi-asserted-by":"crossref","unstructured":"J. Akhtar, A.A. Khan, Z. Ali, R. Haider, M. Shahar Yar, Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities, Eur. J. Med. Chem., 125 (2017) 143-189. 10.1016\/j.ejmech.2016.09.023.","DOI":"10.1016\/j.ejmech.2016.09.023"},{"key":"10.1016\/j.bmc.2022.117111_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.01.039","article-title":"Antiplasmodial and antimalarial activities of quinolone derivatives: An overview","volume":"146","author":"Fan","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2019.01.047","article-title":"Triazole derivatives and their antiplasmodial and antimalarial activities","volume":"166","author":"Chu","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111700","article-title":"1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships","volume":"183","author":"Xu","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0130","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.apsb.2021.07.008","article-title":"Targeting glutamine utilization to block metabolic adaptation of tumor cells under the stress of carboxyamidotriazole-induced nutrients unavailability","volume":"12","author":"Shi","year":"2022","journal-title":"Acta Pharmacol. Sin. B"},{"key":"10.1016\/j.bmc.2022.117111_b0135","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/14756366.2019.1630616","article-title":"Activation of human \u03b1-carbonic anhydrase isoforms I, II, IV and VII with bis-histamine schiff bases and bis-spinaceamine substituted derivatives","volume":"34","author":"Akocak","year":"2019","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0140","doi-asserted-by":"crossref","unstructured":"C.T. Supuran, C. Capasso, Chapter 13 - Acatalytic Carbonic Anhydrases (CAs VIII, X, XI), in: C.T. Supuran, G. De Simone (Eds.) Carbonic Anhydrases as Biocatalysts, Elsevier, Amsterdam, 2015, pp. 239-245.","DOI":"10.1016\/B978-0-444-63258-6.00013-5"},{"key":"10.1016\/j.bmc.2022.117111_b0145","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2022.117111_b0150","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Supuran, Structure and function of carbonic anhydrases","volume":"473","author":"Claudiu","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2022.117111_b0155","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/acsmedchemlett.8b00334","article-title":"Famotidine, an Antiulcer Agent, Strongly Inhibits Helicobacter pylori and Human Carbonic Anhydrases","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2022.117111_b0160","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0165","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acsmedchemlett.7b00399","article-title":"Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous Bases","volume":"8","author":"Nocentini","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2022.117111_b0170","doi-asserted-by":"crossref","unstructured":"A. Kumar, K. Siwach, T. Rom, R. Kumar, A. Angeli, A. Kumar Paul, C.T. Supuran, P.K. Sharma, Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors, Bioorg. Chem., 123 (2022) 105764. 10.1016\/j.bioorg.2022.105764.","DOI":"10.1016\/j.bioorg.2022.105764"},{"key":"10.1016\/j.bmc.2022.117111_b0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/jm301625s","article-title":"Sulfocoumarins (1,2-Benzoxathiine-2,2-dioxides): A Class of Potent and Isoform-Selective Inhibitors of Tumor-Associated Carbonic Anhydrases","volume":"56","author":"Tars","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/metabo10100412","article-title":"Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment","volume":"10","author":"Angeli","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.bmc.2022.117111_b0190","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/jm501798g","article-title":"Carbonic Anhydrase Inhibitors with Dual-Tail Moieties To Match the Hydrophobic and Hydrophilic Halves of the Carbonic Anhydrase Active Site","volume":"58","author":"Tanpure","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0195","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2020.1743676","article-title":"Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery","volume":"15","author":"Supuran","year":"2020","journal-title":"Expert Opin. Drug Disc."},{"key":"10.1016\/j.bmc.2022.117111_b0200","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","article-title":"Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: Solution and X-ray crystallographic studies","volume":"22","author":"Bozdag","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0205","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/17460441.2019.1651289","article-title":"Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery","volume":"14","author":"Nocentini","year":"2019","journal-title":"Expert Opin. Drug Disc."},{"key":"10.1016\/j.bmc.2022.117111_b0210","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/453543","article-title":"Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors","volume":"2015","author":"Pinard","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bmc.2022.117111_b0215","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/ml500196t","article-title":"Carbonic Anhydrase Inhibition with Benzenesulfonamides and Tetrafluorobenzenesulfonamides Obtained via Click Chemistry","volume":"5","author":"Pala","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2022.117111_b0220","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bioorg.2019.01.002","article-title":"Synthesis of novel benzenesulfonamide bearing 1,2,3-triazole linked hydroxy-trifluoromethylpyrazolines and hydrazones as selective carbonic anhydrase isoforms IX and XII inhibitors","volume":"85","author":"Sharma","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0225","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1021\/jm300427m","article-title":"Metallocene-Based Inhibitors of Cancer-Associated Carbonic Anhydrase Enzymes IX and XII","volume":"55","author":"Salmon","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0230","doi-asserted-by":"crossref","unstructured":"C.T. Supuran, V. Alterio, A. Di Fiore, K. D\u2019 Ambrosio, F. Carta, S.M. Monti, G. De Simone, Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one, Med. Res. Rev., 38 (2018) 1799-1836. 10.1002\/med.21497.","DOI":"10.1002\/med.21497"},{"key":"10.1016\/j.bmc.2022.117111_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756360902784425","article-title":"Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies","volume":"24","author":"Ebbesen","year":"2009","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","article-title":"Carbonic anhydrase XII functions in health and disease","volume":"623","author":"Waheed","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.bmc.2022.117111_b0245","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmc.2022.117111_b0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Sign."},{"key":"10.1016\/j.bmc.2022.117111_b0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","article-title":"Carbonic anhydrase IX and acid transport in cancer","volume":"122","author":"Becker","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bmc.2022.117111_b0260","first-page":"1616","article-title":"How and Why Are Cancers Acidic?","volume":"12","author":"Lee","year":"2020","journal-title":"Carbonic Anhydrase IX and the Homeostatic Control of Tumour Extracellular pH, Cancers"},{"key":"10.1016\/j.bmc.2022.117111_b0265","first-page":"1","article-title":"Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors","author":"Lolak","year":"2022","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmc.2022.117111_b0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2022.117111_b0275","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/ja993663t","article-title":"Prediction of Properties from Simulations: Free Energies of Solvation in Hexadecane, Octanol, and Water","volume":"122","author":"Duffy","year":"2000","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2022.117111_b0280","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","article-title":"Esterase activities of human carbonic anhydrases B and C","volume":"242","author":"Verpoorte","year":"1967","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0285","doi-asserted-by":"crossref","first-page":"e1900383","DOI":"10.1002\/ardp.201900383","article-title":"Sulfonamides incorporating ketene N, S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors","volume":"353","author":"Istrefi","year":"2020","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2022.117111_b0290","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/14756366.2020.1746784","article-title":"Synthesis, characterization, biological evaluation and in silico studies of sulfonamide Schiff bases","volume":"35","author":"Durgun","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0295","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1007\/s11030-022-10422-8","article-title":"Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif","volume":"26","author":"G\u00fcle\u00e7","year":"2022","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmc.2022.117111_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103004","article-title":"Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors","volume":"89","author":"T\u00fcrke\u015f","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103897","article-title":"Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, \u03b1-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs","volume":"100","author":"Lolak","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0310","doi-asserted-by":"crossref","unstructured":"S. Askin, H. Tahtaci, C. T\u00fcrke\u015f, Y. Demir, A. Ece, G.A. \u00c7ift\u00e7i, \u015e. Beydemir, Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo [2, 1-b][1, 3, 4] thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors, Bioorg. Chem., (2021) 105009. 10.1016\/j.bioorg.2021.105009.","DOI":"10.1016\/j.bioorg.2021.105009"},{"key":"10.1016\/j.bmc.2022.117111_b0315","first-page":"13347","article-title":"New Isoindole-1, 3-dione Substituted Sulfonamides as Potent Inhibitors of Carbonic Anhydrase and Acetylcholinesterase: Design","volume":"4","author":"G\u00fcndo\u011fdu","year":"2019","journal-title":"Synthesis, and Biological Evaluation, ChemistrySelect"},{"key":"10.1016\/j.bmc.2022.117111_b0320","doi-asserted-by":"crossref","first-page":"e2000102","DOI":"10.1002\/ardp.202000102","article-title":"Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3-diaryltriazene-substituted sulfathiazole derivatives","volume":"353","author":"I\u015f\u0131k","year":"2020","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2022.117111_b0325","doi-asserted-by":"crossref","first-page":"2000282","DOI":"10.1002\/ardp.202000282","article-title":"Novel benzoic acid derivatives: Synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors","volume":"354","author":"Kalayc\u0131","year":"2021","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2022.117111_b0330","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.taap.2016.08.023","article-title":"A new brominated chalcone derivative suppresses the growth of gastric cancer cells in vitro and in vivo involving ROS mediated up-regulation of DR5 and 4 expression and apoptosis","volume":"309","author":"Zhang","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bmc.2022.117111_b0335","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/jmbi.1994.1655","article-title":"Drug-Protein Interactions: Refined Structures of Three Sulfonamide Drug Complexes of Human Carbonic Anhydrase I Enzyme","volume":"243","author":"Chakravarty","year":"1994","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2022.117111_b0340","first-page":"992","article-title":"High-resolution structure of human carbonic anhydrase II complexed with acetazolamide reveals insights into inhibitor drug design, Acta Crystallogr","volume":"65","author":"Sippel","year":"2009","journal-title":"Sect. F"},{"key":"10.1016\/j.bmc.2022.117111_b0345","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00249-017-1256-0","article-title":"Intrinsic thermodynamics of high affinity inhibitor binding to recombinant human carbonic anhydrase IV","volume":"47","author":"Mickevi\u010di\u016bt\u0117","year":"2018","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.bmc.2022.117111_b0350","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2022.117111_b0355","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2022.117111_b0360","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2022.117111_b0365","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pKaprediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2022.117111_b0370","first-page":"1","article-title":"Novel inhibitors with sulfamethazine backbone: Synthesis and biological study of multi-target cholinesterases and \u03b1-glucosidase inhibitors","author":"T\u00fcrke\u015f","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2022.117111_b0375","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and Characterizing Binding Sites and Assessing Druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2022.117111_b0380","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1080\/07391102.2020.1736631","article-title":"Calcium Channel Blockers: Molecular Docking and Inhibition Studies on Carbonic Anhydrase I and II Isoenzymes","volume":"39","author":"T\u00fcrke\u015f","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2022.117111_b0385","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0390","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein\u2212Ligand Complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2020.121542","article-title":"Mannich reaction derived novel boron complexes with amine-bis(phenolate) ligands: synthesis, spectroscopy and in vitro\/in silico biological studies","volume":"927","author":"Kilic","year":"2020","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.bmc.2022.117111_b0400","doi-asserted-by":"crossref","first-page":"e2200132","DOI":"10.1002\/ardp.202200132","article-title":"Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrides as carbonic anhydrase inhibitors","volume":"355","author":"Osmaniye","year":"2022","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2022.117111_b0405","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1021\/ci700271z","article-title":"Search for Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase Using Chemical Similarity, Molecular Docking, and MM-GB\/SA Scoring","volume":"47","author":"Barreiro","year":"2007","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2022.117111_b0410","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ijbiomac.2020.09.043","article-title":"Thiazolyl-pyrazoline derivatives: In vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors","volume":"163","author":"Sever","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmc.2022.117111_b0415","doi-asserted-by":"crossref","first-page":"e2100294","DOI":"10.1002\/ardp.202100294","article-title":"Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds","volume":"354","author":"Sever","year":"2021","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2022.117111_b0420","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1002\/slct.202102082","article-title":"Transition-metal complexes of bidentate schiff-base ligands: in vitro and in silico evaluation as non-classical carbonic anhydrase and potential acetylcholinesterase inhibitors","volume":"29","author":"Ya\u015far","year":"2021","journal-title":"ChemistrySelect"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622005041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622005041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:20:40Z","timestamp":1760836840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622005041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":84,"alternative-id":["S0968089622005041"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117111","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117111"}}